# Strategic Collaboration

MindRank and Borui Cuanghe have announced a strategic collaboration to advance AI-driven radionuclide drug conjugates (RDCs) that use cyclic peptides as targeting ligands, aimed at unmet needs in precision oncology. MindRank contributes its Intera life-science foundation model system, with InteraFold-PEP predicting how cyclic peptides bind target proteins to guide design, screening and optimization; Borui Cuanghe contributes radiopharmaceutical development, radiolabeling and clinical translation, and the two sides iterate AI design against experimental validation. The target ligands must combine high affinity, high selectivity and good developability, and the work is at the collaboration-launch stage.

MindRank and Borui Cuanghe have announced a strategic collaboration to advance AI-driven radionuclide drug conjugates (RDCs) that use cyclic peptides as targeting ligands, aimed at unmet needs in precision oncology. MindRank contributes its Intera life-science foundation model system, with InteraFold-PEP predicting how cyclic peptides bind target proteins to guide design, screening and optimization; Borui Cuanghe contributes radiopharmaceutical development, radiolabeling and clinical translation, and the two sides iterate AI design against experimental validation. The target ligands must combine high affinity, high selectivity and good developability, and the work is at the collaboration-launch stage.

Several Australian universities are collaborating with OpenAI to bring frontier AI tools such as ChatGPT Edu into teaching, clinical simulation and teacher training. A survey commissioned by OpenAI of 1,018 university students found 81% use AI several times a week and 28% have already built an AI agent or assistant. UNSW plans to bring ChatGPT Edu to more than 80,000 students and staff, while the University of Sydney and La Trobe University roll out in stages, with full access scheduled for Semester 1, 2027 and the first quarter of 2027 respectively.

Several Australian universities are collaborating with OpenAI to bring frontier AI tools such as ChatGPT Edu into teaching, clinical simulation and teacher training. A survey commissioned by OpenAI of 1,018 university students found 81% use AI several times a week and 28% have already built an AI agent or assistant. UNSW plans to bring ChatGPT Edu to more than 80,000 students and staff, while the University of Sydney and La Trobe University roll out in stages, with full access scheduled for Semester 1, 2027 and the first quarter of 2027 respectively.

AstraZeneca signed a new strategic drug discovery collaboration and licensing agreement with AI therapeutics company insitro to identify novel targets and advance new programmes for metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. insitro will apply its Virtual Human AI platform, which combines large-scale human and cellular data with AI-enabled target identification and medicine design, to identify causal disease biology and move AstraZeneca-nominated targets from discovery to development candidate. insitro receives a $40 million upfront payment and is eligible for up to approximately $1.46 billion in development and commercial milestones plus single-digit royalties, while AstraZeneca holds exclusive worldwide rights to selected programmes.

AstraZeneca signed a new strategic drug discovery collaboration and licensing agreement with AI therapeutics company insitro to identify novel targets and advance new programmes for metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. insitro will apply its Virtual Human AI platform, which combines large-scale human and cellular data with AI-enabled target identification and medicine design, to identify causal disease biology and move AstraZeneca-nominated targets from discovery to development candidate. insitro receives a $40 million upfront payment and is eligible for up to approximately $1.46 billion in development and commercial milestones plus single-digit royalties, while AstraZeneca holds exclusive worldwide rights to selected programmes.